Lamya

Desogestrel, the active ingredient in Lamya, is a progestin presented as an oral tablet for oral use. It works by suppressing ovulation and altering cervical mucus, providing reliable contraception for women of reproductive age.

GNH USA supplies Lamya as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality, regulatory compliance, and reliable supply chain support for healthcare providers across global markets.

Desogestrel is used as a progestin component in oral contraceptive regimens to prevent pregnancy.

Contraception: provides reliable prevention of pregnancy in women of reproductive age. Menstrual cycle regulation: helps achieve more predictable bleeding patterns and reduces irregular spotting. Hormonal balance: supports progestogenic activity, which can alleviate symptoms such as dysmenorrhea in some users.

Desogestrel may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: mild stomach upset or queasiness. - Headache: transient cranial pain. - Breast tenderness: discomfort or swelling of the breasts. - Irregular bleeding: spotting or changes in menstrual flow.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins or lungs. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Liver dysfunction: jaundice, elevated enzymes, or hepatic impairment.

Before prescribing Desogestrel, consider the following precautions to ensure safe use.

- Thromboembolic risk assessment: evaluate personal or family history of blood clots before initiating therapy. - Smoking status: avoid use in women over 35 who smoke due to increased cardiovascular risk. - Blood pressure monitoring: check for hypertension and manage accordingly during treatment. - Liver function evaluation: assess hepatic health, as liver disease may affect drug metabolism. - Missed dose guidance: provide clear instructions on what to do if a tablet is omitted. - Store at room temperature: keep tablets below 25 °C in the original packaging, protected from moisture and light.

Desogestrel can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Enzyme inducers (e.g., rifampicin, carbamazepine, phenytoin): may reduce contraceptive efficacy. - St. John’s wort: herbal inducer that can diminish hormone levels. - Certain antiepileptics (e.g., phenobarbital): may compromise contraceptive protection.

Moderate Interactions (Monitor Closely): - Antifungal agents (e.g., ketoconazole, itraconazole): may increase hormone concentrations. - HIV protease inhibitors (e.g., ritonavir): can affect hormone metabolism. - Selective serotonin reuptake inhibitors (e.g., fluoxetine): may require monitoring for mood changes.